Heart rate variability in patients with ventricular arrhythmias: Effect of antiarrhythmic drugs
暂无分享,去创建一个
Peter J. Schwartz | D. J. Ewing | P. Schwartz | D. Ewing | J. Neilson | G. Zuanetti | R. Latini | Giulio Zuanetti | R. Latini | James M.M. Neilson
[1] J. Miller,et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. , 1987, The American journal of cardiology.
[2] J. Miller,et al. The independence of cycle length variability and exercise testing on predicting mortality of patients surviving acute myocardial infarction. The Multicenter Postinfarction Research Group. , 1990, The American journal of cardiology.
[3] P. Schwartz,et al. Sympathetic nervous system and cardiac arrhythmias , 1990 .
[4] M. Niemelä,et al. Impaired vagal heart rate control in coronary artery disease. , 1987, British heart journal.
[5] H. Huikuri,et al. Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol. , 1989, Circulation.
[6] S Cerutti,et al. Heart rate variability as an index of sympathovagal interaction after acute myocardial infarction. , 1987, The American journal of cardiology.
[7] D. Wyse,et al. Right and left ventricular function during chronic amiodarone therapy. , 1988, The American journal of cardiology.
[8] R. Cappato,et al. Direct and autonomically mediated effects of oral flecainide. , 1988, The American journal of cardiology.
[9] H T Davis,et al. Ventricular Ectopic Beats and Their Relation to Sudden and Nonsudden Cardiac Death After Myocardial Infarction , 1979, Circulation.
[10] D. Ewing,et al. Cardiac parasympathetic activity during the early hours of acute myocardial infarction. , 1989, British heart journal.
[11] G. Schreiber,et al. Interaction of the antiarrhythmic drug amiodarone with the muscarinic receptor in rat heart and brain. , 1984, Journal of cardiovascular pharmacology.
[12] A. Camm,et al. CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. , 1990, Circulation.
[13] R. Cohen,et al. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. , 1981, Science.
[14] J P Miller,et al. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. , 1984, Circulation.
[15] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[16] F. Witkowski,et al. Mechanisms controlling cardiac autonomic function and their relation to arrhythmogenesis , 1986 .
[17] D. Tepper,et al. Propafenone: a new antiarrhythmic agent. , 1988, American heart journal.
[18] M D Klein,et al. Computer detection of ventricular ectopic beats. , 1970, Computers and biomedical research, an international journal.
[19] A. Beckett,et al. AKUFO AND IBARAPA. , 1965, Lancet.
[20] J. Fleiss,et al. Components of heart rate variability measured during healing of acute myocardial infarction. , 1988, The American journal of cardiology.
[21] R. Cohen,et al. An Efficient Algorithm for Spectral Analysis of Heart Rate Variability , 1986, IEEE Transactions on Biomedical Engineering.
[22] J M Bland,et al. Statistical methods for assessing agreement between two methods of clinical measurement , 1986 .
[23] E. Benfenati,et al. High-performance liquid chromatographic separation and mass spectrometric identification of propafenone, 5-hydroxypropafenone and N-depropylpropafenone. , 1988, Journal of Chromatography A.
[24] S E Smith,et al. Beta-adrenoceptor antagonists increase sinus arrhythmia, a vagotonic effect. , 1986, British journal of clinical pharmacology.
[25] R J Cohen,et al. Beat to beat variability in cardiovascular variables: noise or music? , 1989, Journal of the American College of Cardiology.
[26] A. Miller,et al. Application of a bonded-phase extraction column for rapid sample preparation of flecainide from human plasma for high-performance liquid chromatographic analysis--fluorescence or ultraviolet detection. , 1984, Therapeutic drug monitoring.
[27] M. Thames,et al. Responses of sympathetic nerves to programmed ventricular stimulation. , 1987, Journal of the American College of Cardiology.
[28] J. Paul,et al. β‐Adrenoceptor Blocking Activity of Diprafenone in Anesthetized Dogs: Comparison with Propafenone and Propranolol , 1989, Journal of Cardiovascular Pharmacology.
[29] W. Rogers,et al. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. , 1989, The New England journal of medicine.
[30] D. Ewing,et al. New method for assessing cardiac parasympathetic activity using 24 hour electrocardiograms. , 1984, British heart journal.
[31] S. Evans,et al. The end of the p value? , 1988, British heart journal.
[32] A. Camm,et al. CAST and beyond. Implications of the cardiac arrhythmia suppression trials. By the Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. , 1990, European heart journal.
[33] R. Colvin,et al. Interaction of amiodarone and desethylamiodarone with the cardiac muscarinic receptor in vitro. , 1989, Journal of molecular and cellular cardiology.
[34] R J Cohen,et al. Comparison of time- and frequency domain-based measures of cardiac parasympathetic activity in Holter recordings after myocardial infarction. , 1989, The American journal of cardiology.
[35] R J Cohen,et al. Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis. , 1988, The American journal of cardiology.
[36] B. Lown,et al. Sudden cardiac death: the major challenge confronting contemporary cardiology. , 1979, The American journal of cardiology.
[37] R J Cohen,et al. Analysis of long term heart rate variability: methods, 1/f scaling and implications. , 1988, Computers in cardiology.
[38] A. Malliani,et al. Premature ventricular contractions and reflex sympathetic activation in cats. , 1989, Cardiovascular research.
[39] S. Connolly,et al. Myocardial disposition of amiodarone in the dog. , 1983, The Journal of pharmacology and experimental therapeutics.
[40] H. L. Stone,et al. Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death. , 1984, Circulation.
[41] M. Turiel,et al. Power Spectral Analysis of Heart Rate and Arterial Pressure Variabilities as a Marker of Sympatho‐Vagal Interaction in Man and Conscious Dog , 1986, Circulation research.
[42] M. Weir,et al. The Cardiac Arrhythmia Suppression Trial Investigators: Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression After Myocardial Infarction. , 1990 .
[43] L. Horowitz,et al. Influence of left ventricular dysfunction on flecainide therapy. , 1987, Journal of the American College of Cardiology.
[44] T. Graboys,et al. Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs. , 1982, The American journal of cardiology.
[45] G. Casolo,et al. Decreased spontaneous heart rate variability in congestive heart failure. , 1989, The American journal of cardiology.
[46] P. Polster,et al. The adrenergic antagonism of amiodarone. , 1976, Biochemical pharmacology.